FDA advisers recommend that Covid-19 boosters for fall should drop original strain

"A panel of outside advisers to the US Food and Drug Administration voted [...] that Covid-19 vaccines should be updated for the fall as the pandemic continues to recede from daily life but the coronavirus shows no sign of slowing its evolution."

FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting

"On June 15, 2023, the VRBPAC [met] in open session to discuss and make recommendations on the selection of strain(s) to be included in periodic updated COVID-19 vaccines."

Articles by IASO referenced in FDA brief: 

Wang Q, et al. (2023a). Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine. bioRxiv. 2023:2023.05.03.539268. https://doi.org/10.1101/2023.05.03.539268

Wang, Q., et al. (2023b). Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell, 186(2), 279–286.e8. 

https://doi.org/10.1016/j.cell.2022.12.018 

New immunology study of U-M employees seeks answers on coronavirus reinfections

"In ancient Greece, people who were sick would seek the help of IASO, the goddess of cures, remedies and modes of healing. Now, University of Michigan researchers are counting on a different IASO..."

​IASO, the Greek goddess of recuperation from illness

Funded By

This study was approved by the University of Michigan Medical School Institutional Review Board  (protocol number: HUM00184533). The IRB-Med can be contacted with concerns at:

Address: 2800 Plymouth Road, Building 520, Room 3214, Ann Arbor, MI 48109-2800; e-mail: irbmed@umich.edu  Telephone: 734-763-4768